References
- Viscoli, C. (2002) "Management of infection in cancer patients: studies of the EORTC International Antimicrobial Therapy Group (IATG)", European Journal of Cancer, 38, S82 —S87.
- Elting, L.S., Rubenstein, E.B., Rolston, K.V.I., et al. (1997) "Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials", Clinical Infectious Diseases, 25, 247–259.
- Talcott, J.A., Siegel, R.D., Finberg, R., et al. (1992) "Risk assessment in cancer patients with fever and neutropenia: a rospective, two-center validation of a prediction rule", Journal of Clinical Oncology, 10, 316–322.
- Klastersky, J., Paesamans, M., Rubenstein, E.B., et al. (2000) "The Multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients", Journal of Clinical Oncology, 18, 3038 — 3051.
- Kern, W.V., Cometta, A., de Bock, R., et al. (1999) "Oral versus intravenous empiric therapy for fever in patients with granulocyto-penia who are receiving cancer chemotherapy", New England Journal of Medicine, 341, 312–318.
- Freifeld, A., Marchigiani, D., Walsh, T., et al. (1999) "A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy", New England Journal of Medicine, 341, 305 — 311.
- Marchetti, 0. and Calandra, T. (2002) "Infections in neutropenic cancer patients", The Lancet, 359, 723–724.
- Ascioglu, S., Rex, J.H., de Pauw, B., et al. (2002) "Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hemopoietic stem cell transplants: an international consensus", Clinical Infectious Diseases, 34, 7–14.
- Armin°, L., Vegna, M.L., Camera, A, et al. (2002) "Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study", Blood, 99, 863–871.
- Mandelli, M.F., Armin°, L., Vegna, M.L., et al. (2001) Interim analysis of the GIMEMA ALL 0496 trial for adult acute lymphoblastic leukemia (ALL). In Program and abstract, 6th Annual Meeting of the European Haematology Association. Abstract 692a.
- Offidani, M., Corvatta, L., Centurioni, R., et al. (2003) "High dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia", The Hematology Journal, 4, 47–53.
- Kantarjian, H.M., O'Brian, S., Smith, T.L., et al. (2000) "Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukaemia", Journal of Clinical Oncology, 3, 547–561.
- Hallbook, H., Simonsson, B., Ahlgren, T., et al. (2002) "High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia", British Journal of Haematology, 118, 748–754.
- Wisplinghoff, H., Seifert, H., Wenzel, R.P., et al. (2003) "Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States", Clinical Infectious Diseases, 36, 1103–1110.
- Offidani, M., Corvatta, L., Olivieri, A., et al. (1999) "Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF", Bone Marrow Transplanta-tion, 24, 1079–1087.
- Zervos, M.J., Hershberger, E., Nicolau, D.P., et al. (2003) "Relationship between fluoroquinolones use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000", Clinical Infectious Diseases, 37, 1643 — 1648.
- Garcia-Suarez, J., Krsnik, I., Reyes, E., et al. (2003) "Elderly haematological patients with chemotherapy-induced febrile neutro-penia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy", British Journal of Haematology, 120, 209–216.